Zobrazeno 1 - 10
of 83
pro vyhledávání: '"D. Bethke"'
Autor:
Morgan Shell, James D. Bethke
Publikováno v:
Indiana Law Review. 51:111-143
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1516fc6f3e3c4a2f5915a72547e624be
https://doi.org/10.18060/4806.1184
https://doi.org/10.18060/4806.1184
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Robert D. Bethke
Publikováno v:
Michigan Historical Review. 43:102-103
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa370bf3fd364e4b3ef27ae49e47d55d
https://doi.org/10.1353/mhr.2017.0030
https://doi.org/10.1353/mhr.2017.0030
Publikováno v:
Chronobiology International. 27:1843-1853
The human circadian system is known to affect the pharmacokinetics and pharmacodynamics of several classes of respiratory disease medications. The current study involving 16 healthy adults investigated if the time-of-day of dosing of roflumilast, a n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3a738e9d7def3ff05cec687dbc18ec6
https://doi.org/10.3109/07420528.2010.520398
https://doi.org/10.3109/07420528.2010.520398
Autor:
Melanie Gleason, Kathleen A. Neville, Susan M. Abdel-Rahman, Stanley J. Szefler, Karl Zech, Gregory L. Kearns, Rolf Herzog, Thomas D. Bethke, Gezim Lahu
Publikováno v:
The Journal of Clinical Pharmacology. 48:978-985
Roflumilast is an orally administered phosphodiesterase 4 inhibitor that has potential for use in pediatric patients with asthma. The pharmacokinetics of roflumilast and roflumilast N-oxide were examined in adolescents and children with stable mild t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a74b558d0b2e526e6036c58c0142a89b
https://doi.org/10.1177/0091270008319466
https://doi.org/10.1177/0091270008319466
Publikováno v:
GMS German Medical Science; VOL: 13; DOC02 /20150127/
GMS German Medical Science, Vol 13, p Doc02 (2015)
GMS German Medical Science
GMS German Medical Science, Vol 13, p Doc02 (2015)
GMS German Medical Science
Objective: The objective of this project was to evaluate the quality and quantity of initial applications for a clinical trial according to § 7 of the German Good Clinical Practice (GCP) ordinance (German: GCP-Verordnung, GCP-V), the quality of eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31aa1f67558d6c2d3a0aea3e1e8aac63
http://nbn-resolving.de/urn:nbn:de:0183-0002064
http://nbn-resolving.de/urn:nbn:de:0183-0002064
Autor:
Gregory K, Reed, Cathleen C, Piazza, Meeta R, Patel, Stacy A, Layer, Melanie H, Bachmeyer, Stephanie D, Bethke, Katharine A, Gutshall
Publikováno v:
Journal of Applied Behavior Analysis. 37:27-42
In the current investigation, we evaluated the relative effects of noncontingent reinforcement (NCR), escape extinction, and a combination of NCR and escape extinction as treatment for the feeding problems exhibited by 4 children. For each participan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa874fb93d645b352822af855d0f8c13
https://doi.org/10.1901/jaba.2004.37-27
https://doi.org/10.1901/jaba.2004.37-27
Autor:
T D Bethke, Romuald J. Adamek
Publikováno v:
American Journal of Gastroenterology. 93:1919-1924
OBJECTIVE: Eradication of Helicobacter pylori (H. pylori) is recommended as the first-line therapeutic concept for reliable long-term prevention of duodenal ulcer (DU) relapse. Current treatment regimens vary in efficacy, complexity, and compliance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03366864319fad63e53bfa94c71c096c
https://doi.org/10.1111/j.1572-0241.1998.459_a.x
https://doi.org/10.1111/j.1572-0241.1998.459_a.x